Intrinsic Value of S&P & Nasdaq Contact Us

Agilent Technologies, Inc. A NYSE

NYSE • Healthcare • Medical - Diagnostics & Research • US • USD

SharesGrow Score
74/100
5/7 Pass
SharesGrow Intrinsic Value
$120.45
+0%
Analyst Price Target
$168.18
+39.7%

Agilent Technologies, Inc. (A) reported total assets of $12.81B and total liabilities of $5.91B for quarter ending 2026-01-31, resulting in total equity of $6.91B.

The company held $1.76B in cash and short-term investments. Total debt stood at $3.35B, with net debt of $1.6B. The Debt-to-Equity (D/E) ratio was 0.49 (conservative).

Current ratio is 2.07, indicating strong short-term liquidity. Interest coverage is 14.1x (strong).

Criteria supported by this page:

  • HEALTH (83/100, Pass) — Debt-to-Equity of 0.49, current ratio of 2.07, interest coverage 14.1x — balance sheet is strong
  • MOAT (76/100) — Total assets $12.81B and equity $6.91B support the company's competitive scale
  • VALUE (58/100) — Debt-to-Equity 0.49 contributes to the overall valuation risk assessment

Overall SharesGrow Score: 74/100 with 5/7 criteria passed.

SharesGrow 7-Criteria Score
74/100
SG Score
View full scorecard →
~
VALUE
58/100
Price-to-Earnings & upside
→ Valuation
FUTURE
85/100
Analyst consensus
→ Forecast
PAST
100/100
→ Income
HEALTH
83/100
Debt-to-Equity & liquidity
Proven by this page
MOAT
76/100
Proven by this page
~
GROWTH
45/100
→ Income
INCOME
70/100
→ Income
Agilent Technologies, Inc. Balance Sheet History
Metric Q1 FY2026 Q4 FY2025 Q3 FY2025 Q2 FY2025
Total Assets $12.81B$12.73B$12.23B$12.16B
Total Liabilities $5.91B$5.99B$5.86B$6.02B
Total Debt $3.35B$3.35B$3.41B$3.5B
Cash & Investments $1.76B$1.79B$1.54B$1.49B
Total Stockholders Equity $6.91B$6.74B$6.37B$6.14B
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message